BONDULC 40MCG/ML OPH GTT SOL 3X2,5ML

What is the maximum co-payment for BONDULC?

If the insurance company contributes, the maximum co-payment is 196,69 Kč. The maximum pharmacy price is 654,86 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, zkontrolujte ale specializaci předepisujího lékaře níže.

Does BONDULC have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

458,17 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

The medicine has no indication restriction. Its reimbursement is not conditional on a specific diagnosis or clinical condition.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe BONDULC?

ophthalmology

What is the composition of BONDULC?

Travoprost (0,1 mg), solution benzalkonium-chloridu, neznámá látka s kódem 19654, trometamol, dihydrát dinatrium-edetátu, kyselina boritá, mannitol, solution hydroxidu sodného, voda pro injekci (2,5 ml), neznámá látka s kódem -1, čištěná voda (2,5 ml). More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Documents could not be found

Which medicines are similar to BONDULC?

The medicine belongs to ATC group S01EE04 – TRAVOPROST. Medicines with the same active substance can be found here.

Who manufactures BONDULC?

Teva B.V., Haarlem (NL)

Is the medicine in shortage?

The latest report from the manufacturer is from 18. 12. 2023. Production was terminated with effect from 11. 4. 2024. The manufacturer lists medicines with the following code as a potential substitute: